Find API Reference Price of Levomenol on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: (-)-alpha-bisabolol, 23089-26-1, Alpha-bisabolol, Kamillosan, Bisabolol, Alpha-(-)-bisabolol
Molecular Formula
C15H26O
Molecular Weight
222.37  g/mol
InChI Key
RGZSQWQPBWRIAQ-CABCVRRESA-N
FDA UNII
24WE03BX2T

Levomenol
bisabolol is a natural product found in Santolina pectinata, Santolina villosa, and other organisms with data available.
1 2D Structure

Levomenol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol
2.1.2 InChI
InChI=1S/C15H26O/c1-12(2)6-5-11-15(4,16)14-9-7-13(3)8-10-14/h6-7,14,16H,5,8-11H2,1-4H3/t14-,15+/m1/s1
2.1.3 InChI Key
RGZSQWQPBWRIAQ-CABCVRRESA-N
2.1.4 Canonical SMILES
CC1=CCC(CC1)C(C)(CCC=C(C)C)O
2.1.5 Isomeric SMILES
CC1=CC[C@H](CC1)[C@](C)(CCC=C(C)C)O
2.2 Other Identifiers
2.2.1 UNII
24WE03BX2T
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (+)-4-epi-alpha-bisabolol

2. Bisabolol

3. Bisabolol, (+)-isomer

4. Bisabolol, (-)-isomer

2.3.2 Depositor-Supplied Synonyms

1. (-)-alpha-bisabolol

2. 23089-26-1

3. Alpha-bisabolol

4. Kamillosan

5. Bisabolol

6. Alpha-(-)-bisabolol

7. .alpha.-bisabolol

8. Levomenol [inn]

9. (-)-.alpha.-bisabolol

10. (-)-6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol

11. Alpha-bisabolol (-)-form

12. Bisabolol, (-)-.alpha.

13. (2s)-6-methyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol

14. .alpha.-bisabolol, (-)-

15. Chebi:125

16. .alpha.-bisabolol (-)-form

17. 24we03bx2t

18. Fema No. 4666

19. (.alpha.s,1s)-.alpha.-bisabolol

20. 3-cyclohexene-1-methanol, A,4-dimethyl-a-(4-methyl-3-pentenyl)-,(as,1s)-

21. 3-cyclohexene-1-methanol, Alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphas,1s)-

22. Levomenolum

23. Kamilosan

24. ((-))-6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol

25. (s)-6-methyl-2-((s)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol

26. 515-69-5

27. 1-alpha-bisabolol

28. Alpha-bisabolol, L-

29. Levomenolum [inn-latin]

30. Unii-24we03bx2t

31. Bisbalol

32. Ccris 9081

33. L-alpha-bisabolol

34. Levomenol, Inn

35. 3-cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [s-(r*,r*)]-

36. (-)-a-bisabolol

37. Einecs 245-423-3

38. L-.alpha.-bisabolol

39. .alpha.-bisabolol, L-

40. Bisabolol [inci]

41. (-)- Alpha -bisabolol

42. .alpha.-(-)-bisabolol

43. Bisabolol [vandf]

44. Levomenol [mart.]

45. (-)--bisabolol

46. Alpha-(-)bisabolol

47. Levomenol [usp-rs]

48. Levomenol [who-dd]

49. Dsstox_cid_22094

50. Dsstox_rid_79924

51. Dsstox_gsid_42094

52. Schembl24989

53. Chembl1096927

54. Dtxsid4042094

55. (-)-(4s,8s)-alpha-bisabolol

56. Hy-n6967

57. Zinc1849759

58. [s-(r*,r*)]-.alpha.-bisabolol

59. Tox21_301375

60. 5-hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (-)-

61. Bdbm50382730

62. Mfcd03412455

63. Nsc782530

64. Levomenol 100 Microg/ml In Methanol

65. Db13153

66. Lmpr0103060001

67. Nsc-782530

68. (-)-alpha-bisabolol, >=93% (gc)

69. (-)-alpha-bisabolol(-)-alpha-bisabolol

70. Ncgc00255987-01

71. (-)-alpha-bisabolol, Analytical Standard

72. .alpha.-bisabolol (-)-form [mi]

73. Cas-23089-26-1

74. Cs-0028206

75. Alpha-bisabolol 1000 Microg/ml In Isopropanol

76. C09621

77. Q179896

78. J-014978

79. (-)-alpha-bisabolol, Primary Pharmaceutical Reference Standard

80. Levomenol, United States Pharmacopeia (usp) Reference Standard

81. (-)-.alpha.-bisabolol (constituent Of Chamomile) [dsc]

82. 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, (-)-

83. 5-hepten-2-ol, 6-methyl-2-(4- Methyl-3-cyclohexen-1-yl), (-)-

84. [s-(r*,r*)]-.alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol

85. 3-cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (-)-

86. 3-cyclohexene-1-methanol, Alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (.alpha.s,1s)-

87. Alpha,4-dimethyl-alpha-(4-methyl-3-penten-1-yl)-(alphas,1s)-3-cyclohexene-1-methanol

88. 3-cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-penten-1-yl)-, (.alpha.s,1s)-

89. 3-cyclohexene-1-methanol, Alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (s-(theta,theta))-

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 222.37 g/mol
Molecular Formula C15H26O
XLogP33.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count4
Exact Mass222.198365449 g/mol
Monoisotopic Mass222.198365449 g/mol
Topological Polar Surface Area20.2 Ų
Heavy Atom Count16
Formal Charge0
Complexity284
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Levomenol has been known to elicit a number of potentially beneficial pharmacological effects, including anti-irritant, anti-inflammatory, and anti-microbial actions. Bisabolol is also demonstrated to enhance the percutaneous absorption of certain molecules


5 Pharmacology and Biochemistry
5.1 Pharmacology

Levomenol is an anti-inflammatory and natural moisturizing agent that has been found to diminish the signs of photodamage, reduce pruritus, and ameliorate skin texture and elasticity.


5.2 Absorption, Distribution and Excretion

Absorption

The purpose of the present investigations was to study the cutaneous absorption of sesquiterpenic alcohol, the major active principle of chamomile. For these investigations 14C-labelled levomenol ((-)-6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol; (-)-alpha-bisabolol) was prepared by biochemical incorporation of [14C]-acetate into the molecule. 5 h after topical application of the radiolabelled substance onto nude mice half of the radioactivity was found in the skin. The other part was measured in tissue and organes. 90% of this radioactivity was analysed as intact levomenol.


Volume of Distribution

To demonstrate the distribution of the substance in the skin a part of this tissue was cutted into horizontal slices by a cryotome. From the slices autoradiograms were produced. The densitometric measuration showed that there was a fast penetration of levomenol into the skin. 5 h after the topical application the substance was displaced from outermost to innermost areas. From these results a fast cutaneous absorption and a long therapeutical effect of the antiphlogistic and spasmolytic levomenol in the skin can be expected.


Global Sales Information

Do you need Business Intel? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty